Launch of New MetID Services
Hypha Discovery is excited to announce that we have extended our metabolite identification services to include LC-MS/MS-based MetID, complementing our established expertise in metabolite synthesis and NMR-based structure elucidation.
End-to-end MetID solution
Our LC-MS/MS MetID services supports:
- Detection and characterisation of metabolic soft spots in early-stage compounds
- In-depth in vitro biotransformation studies of lead candidates and beyond
- Structural elucidation of metabolites, including synthesis options using surrogate systems
By integrating LC-MS/MS with our existing NMR and metabolite synthesis platforms, we offer a comprehensive, end-to-end solution for metabolite identification and structure confirmation – ideal for advancing candidates through preclinical development.
Introductory offer: Complimentary metabolite synthesis screening
To help you get the most from your MetID study, we’re offering free screening of your compound using our PolyCYPs and PolyUGTs metabolite synthesis kits for 6 months after delivery of your MetID report.
This exclusive offer for Hypha’s MetID clients facilitates metabolite generation for definitive structure elucidation by NMR spectroscopy, and helps accelerate downstream biological testing.
Download a MetID services brochure.
